Electron transfer complexes I and IV of platelets are abnormal in Parkinson's disease but normal in Parkinson-plus syndromes

Cited by (220)

Items 101–200 of 220

1. Dopaminergic function in a family with the PARK6 form of autosomal recessive Parkinson’s syndrome
   Kirn R. Kessler, N Hamscho, B Morales · 2005 · Journal of Neural Transmission
2. Defects of cytochrome c oxidase in the substantia nigra of Parkinson's disease: An immunohistochemical and morphometric study
   Kyoko Itoh, Serge Weis, Parviz Mehraein, Josef Müller‐Höcker · 1997 · Movement Disorders
3. Decreased platelet glutamate uptake and genetic risk factors in patients with Parkinson's disease
   Ferrarese, C., Tremolizzo, L., Rigoldi, M., Sala, G., Brighina, L., Ricci, G., Albizzati, M. G., Piolti, R., Crosti, F., Dalpr�, L. et al. · 2001 · Neurological Sciences
4. Electrophoretic separation of multiprotein complexes from blood platelets and cell lines: Technique for the analysis of diseases with defects in oxidative phosphorylation
   Hermann Schägger, Herman Bentlage, W. Ruitenbeek, Kathy Pfeiffer, Stefan Rotter, Christof Rother, Andrea Böttcher‐Purkl, Edgar Lodemann · 1996 · Electrophoresis
5. Mitochondrial dysfunction – a pathogenetic factor in Parkinson’s disease
   Heinz Reichmann, Bernd Janetzky · 2000 · Journal of Neurology
6. A Ketone Ester Drink Enhances Endurance Exercise Performance in Parkinson’s Disease
   Nicholas G. Norwitz, David Dearlove, Meng Lü, Kieran Clarke, Helen Dawes, Michele T. Hu · 2020 · Frontiers in Neuroscience
7. Hallmarks and Molecular Tools for the Study of Mitophagy in Parkinson’s Disease
   Thomas Goiran, Mohamed A. Eldeeb, Cornelia E. Zorca, Edward A. Fon · 2022 · Cells
8. Glutamate Receptor Dysregulation and Platelet Glutamate Dynamics in Alzheimer’s and Parkinson’s Diseases: Insights into Current Medications
   Deepa Gautam, Ulhas Pandurang Naik, Meghna Ulhas Naik, Santosh Kumar Yadav, Rameshwar Nath Chaurasia, Debabrata Dash · 2023 · Biomolecules
9. Systems biology analysis of the proteomic alterations induced by MPP+, a Parkinson's disease-related mitochondrial toxin
   C. Monti, Heather Bondi, A. Urbani, M. Fasano, T. Alberio · 2015 · Frontiers in Cellular Neuroscience
10. Does Mitochondrial DNA Play a Role in Parkinson's Disease? A Review of Cybrid and Other Supportive Evidence
    Russell Howard Swerdlow · 2011 · Antioxidants and Redox Signaling
11. Dopamine oxidation facilitates rotenone-dependent potentiation of N-methyl-d-aspartate currents in rat substantia nigra dopamine neurons
    Yan Wu, Steven W. Johnson · 2011 · Neuroscience
12. Characterization of Cybrid Cell Lines Containing mtDNA from Huntington's Disease Patients
    Russell Howard Swerdlow, Janice K. Parks, David Samuel Cassarino, Alfred T. Shilling, James P. Bennett, Madaline B. Harrison, William Davis Parker · 1999 · Biochemical and Biophysical Research Communications
13. Proteomic Approach to Studying Parkinson's Disease
    Jing Zhang, David R. Goodlett · 2004 · Molecular Neurobiology
14. Cytoplasmic Transfer of Platelet mtDNA from Elderly Patients with Parkinson's Disease to mtDNA-less HeLa Cells Restores Complete Mitochondrial Respiratory Function
    Yuko Aomi, Chu-Shih Chen, Kazuto Nakada, Sayaka Ito, Kotoyo Isobe, Haruka Murakami, Shinya Kuno, Masato Tawata, Rumiko Matsuoka, Hidehiro Mizusawa et al. · 2001 · Biochemical and Biophysical Research Communications
15. Brain Mitochondrial Complex I Inactivation by Oxidative Modification
    Juan Bautista, Raquel Corpas, Rosa Ramos, Olga Cremades, Juan Fco Gutierrez-Gil, Salvador Alegre · 2000 · Biochemical and Biophysical Research Communications
16. Mitochondrial Changes in Platelets Are Not Related to Those in Skeletal Muscle during Human Septic Shock
    Alessandro Protti, Francesco Fortunato, Maria Luisa Caspani, Mauro Pluderi, Valeria Lucchini, N. Grimoldi, Luigi Piero Solimeno, Gigliola Fagiolari, Patrizia Ciscato, Samis M. A. Zella et al. · 2014 · PLoS ONE
17. Oxygen dependence of flux control of cytochrome c oxidase – implications for mitochondrial diseases
    Falk R. Wiedemann, Wolfram S. Kunz · 1998 · FEBS Letters
18. Expression of a Truncated Human Tau Protein Induces Aqueous-Phase Free Radicals in a Rat Model of Tauopathy: Implications for Targeted Antioxidative Therapy
    Martin Cente, Peter Filipčík, Stanislava Mandakova, Norbert Žilka, Gabriela Krajciova, Michal Novák · 2009 · Journal of Alzheimer s Disease
19. Pathophysiology of Parkinson's disease: Mitochondria, alpha-synuclein and much more…
    Tiphaine Rouaud, Anne-Gaëlle Corbillé, Laurène Leclair‐Visonneau, Adrien de Guilhem de Lataillade, Arthur Lionnet, Cécile Preterre, Philippe Damier, Pascal Derkinderen · 2020 · Revue Neurologique
20. Boosting mitochondrial health to counteract neurodegeneration
    Johannes Burtscher, Mario Romani, Greta Bernardo, Traian Popa, Elena Ziviani, Friedhelm Christoph Hummel, Vincenzo Sorrentino, Grégoire Paul Millet · 2022 · Progress in Neurobiology
21. Neuroproteomics as a promising tool in Parkinson’s disease research
    Ilse Sanet Pienaar, Willie M. U. Daniels, Jürgen Götz · 2008 · Journal of Neural Transmission
22. Biomarkers for prediction and targeted prevention of Alzheimer’s and Parkinson’s diseases: evaluation of drug clinical efficacy
    Silvia A. Mandel, Micaela Morelli, Ilan J. Y. Halperin, Amos D. Korczyn · 2010 · The EPMA Journal
23. Platelet mitochondrial dysfunction and mitochondria-targeted quinone-and hydroquinone-derivatives: Review on new strategy of antiplatelet activity
    Manuel Fuentes, Ramiro Araya‐Maturana, Iván F. Palomo, Eduardo Fuentes Q · 2018 · Biochemical Pharmacology
24. A synthetic cell permeable antioxidant protects neurons against acute oxidative stress
    Nicola J. Drummond, Nick O. Davies, Janet E. Lovett, Mark R. Miller, Graeme Cook, Thomas Becker, Catherina Gwynne Becker, Donald B. McPhail, Tilo Kunath · 2017 · Scientific Reports
25. The mitochondrial common deletion in Parkinson's disease and related movement disorders
    J Zhang, Thomas Jude Montine, Mark A. Smith, Sandra L. Siedlak, G Gu, David Robertson, George L. Perry · 2002 · Parkinsonism & Related Disorders
26. The unresolved role of mitochondrial DNA in Parkinson's disease: An overview of published studies, their limitations, and future prospects
    Amica Corda Müller-Nedebock, Rebecca R. Brennan, Marianne Venter, Ilse Sanet Pienaar, Francois Hendrikus van der Westhuizen, Joanna L. Elson, Owen A. Ross, Soraya Bardien · 2019 · Neurochemistry International
27. Metabolic Consequences of the CytochromecOxidase Deficiency in Brain of Copper‐Deficient MovbrMice
    Wolfram S. Kunz, Andrey V. Kuznetsov, Joseph F. Clark, Irene Tracey, Christian Erich Elger · 1999 · Journal of Neurochemistry
28. Electron Transport Disturbances and Neurodegeneration: From Albert Szent-Györgyi’s Concept (Szeged) till Novel Approaches to Boost Mitochondrial Bioenergetics
    Levente Szalárdy, Dénes Zádori, Péter Klivènyi, József Toldi, László Vécsei · 2015 · Oxidative Medicine and Cellular Longevity
29. Coenzyme Q10 and its effects in the treatment of neurodegenerative diseases
    Graciela Cristina dos Santos, Lusânia Maria Greggi Antunes, Antonio Cardozo dos Santos, María de Lourdes Pires Bianchi · 2009 · Brazilian Journal of Pharmaceutical Sciences
30. Hydrogen peroxide removal and glutathione mixed disulfide formation during metabolic inhibition in mesencephalic cultures
    Julie Ehrhart, Gail Duffy Zeevalk · 2001 · Journal of Neurochemistry
31. Reduced NADH coenzyme Q dehydrogenase activity in platelets of Parkinson's disease, but not Parkinson plus patients, from an Indian population
    Merina Varghese, Mritunjay Pandey, Ananda Samanta, Prasanta Kumar Gangopadhyay, Kochupurackal P. Mohanakumar · 2009 · Journal of the Neurological Sciences
32. MPTP
    Joyce E. Royland, J. William Langston · 1998 · Humana Press eBooks
33. Rotenone Susceptibility Phenotype in Olfactory Derived Patient Cells as a Model of Idiopathic Parkinson’s Disease
    Mariyam Murtaza, Jianguo Shan, Nicholas Matigian, Michael Todorovic, Anthony L. Cook, S. Ravishankar, Lan‐Feng Dong, Jiřı́ Neužil, Peter A. Silburn, Alan Mackay‐Sim et al. · 2016 · PLoS ONE
34. Does mitochondrial respiratory chain dysfunction have a role in common neurodegenerative disorders?
    Edward Byrne · 2002 · Journal of Clinical Neuroscience
35. Sulfonylurea-sensitive potassium current evoked by sodium-loading in rat midbrain dopamine neurons
    Vincent Seutin, Ke Shen, R. ALAN NORTH · 1996 · Neuroscience
36. Inhibition of striatal energy metabolism produces cell loss in the ipsilateral substantia nigra
    Patricia K. Sonsalla, Lawrence Manzino, Christopher M. Sinton, Chang‐Lin Liang, D.C. German, G.D. Zeevalk · 1997 · Brain Research
37. Ketotherapeutics for neurodegenerative diseases
    Nicholas G. Norwitz, Javier Gilbert‐Jaramillo, Kieran Clarke, Adrián Soto-Mota · 2020 · International review of neurobiology
38. Protection of dichlorvos induced oxidative stress and nigrostriatal neuronal death by chronic Coenzyme Q10 pretreatment
    Balachandran Krishnamma Binukumar, Nidhi Gupta, Amanjit Bal, Kiran Dip Gill · 2011 · Toxicology and Applied Pharmacology
39. Oxidative stress during energy impairment in mesencephalic cultures is not a downstream consequence of a secondary excitotoxicity
    G.D. Zeevalk, Laura P. Bernard, William J. Nicklas · 2000 · Neuroscience
40. Proteomics as a new paradigm to tackle Parkinson’s disease research challenges
    Virginie Licker, Pierre R. Burkhard · 2014 · Translational Proteomics
41. Biomarkers for Evaluation of Clinical Efficacy of Multipotential Neuroprotective Drugs for Alzheimer's and Parkinson's Diseases
    Ilan J. Y. Halperin, Micaela Morelli, Amos D. Korczyn, Moussa B. H. Youdim, Silvia A. Mandel · 2008 · Neurotherapeutics
42. Oxidative phosphorylation enzyme complexes in caloric restriction
    Abdullah Olgun, Şerif Akman, Muhittin Abdulkadir Serdar, Türker Kutluay · 2002 · Experimental Gerontology
43. Brain Damage - Bridging Between Basic Research and Clinics
    Alina González-Quevedo · 2012 · InTech eBooks
44. OXPHOS toxicogenomics and Parkinson's disease
    Ester López‐Gallardo, Ruth Iceta, Eldris Iglesias, Julio Montoya, Eduardo Ruiz‐Pesini · 2011 · Mutation Research/Reviews in Mutation Research
45. Role of free radical and antioxidant imbalance in pathogenesis of Parkinson's disease.
    Shashikant Nikam, Padmaja Nikam, S. K. Ahaley · 2009
46. Low selenium diet induces tyrosine hydroxylase enzyme in nigrostriatal system of the rat
    Marina Romero‐Ramos, Jose Luis Venero, Josefina Cano, Alberto Machado · 2000 · Molecular Brain Research
47. NMDA Receptors Modulate Dopamine Loss due to Energy Impairment in the Substantia Nigra but not Striatum
    Gail Duffy Zeevalk, Lawrence Manzino, Patricia K. Sonsalla · 2000 · Experimental Neurology
48. Effects of enhancing mitochondrial oxidative phosphorylation with reducing equivalents and ubiquinone on 1-methyl-4-phenylpyridinium toxicity and complex I–IV damage in neuroblastoma cells
    ELIZABETH A. MAZZIO, Karam F. A. Soliman · 2004 · Biochemical Pharmacology
49. Mitochondrial Dysfunction in Parkinson’s Disease
    Russell Howard Swerdlow, Janice K. Parks, Scott W. Miller, John N. Davis, Patricia A. Trimmer, Jeremy B. Tuttle, James P. Bennett, G. Frederick Wooten, Robert E. Davis, William Davis Parker · 1998 · Advances in behavioral biology
50. Early Detection of Parkinson??s Disease
    Rocco Di Paola, Ryan J. Uitti · 1996 · Drugs & Aging
51. Monocytohigh-density lipoprotein ratio has a high predictive value for the diagnosis of multiple system atrophy and the differentiation from Parkinson’s disease
    Lijuan Jiang, Zhen Zhong, Juan Huang, Hetao Bian, Wei Huang · 2022 · Frontiers in Aging Neuroscience
52. Platelet mitochondrial activity and pesticide exposure in early Parkinson's disease
    Jeff M. Bronstein, Kimberly C. Paul, Laurice Yang, Richard Haas, Clifford W. Shults, Thuy P. Le, Beate R. Ritz · 2015 · Movement Disorders
53. Deletion of DJ-1 in rats affects protein abundance and mitochondrial function at the synapse
    Mohannad A. Almikhlafi, Kelly L. Stauch, Lance M. Villeneuve · 2020 · Scientific Reports
54. Mitochondrial-Associated Membranes in Parkinson’s Disease
    Nobutaka Hattori, Taku Arano, Taku Hatano, Akio Mori, Yuzuru Imai · 2017 · Advances in experimental medicine and biology
55. The Impact of microRNAs on Mitochondrial Function and Immunity: Relevance to Parkinson’s Disease
    Beatriz F. S. Guedes, Sandra M. Cardoso, A. Raquel Esteves · 2023 · Biomedicines
56. Mitochondrial Respiration in Intact Peripheral Blood Mononuclear Cells and Sirtuin 3 Activity in Patients with Movement Disorders
    S. Michalak, Jolanta Florczak‐Wyspianska, Joanna Rybacka-Mossakowska, Wojciech Ambrosius, Krystyna Osztynowicz, Aleksandra Baszczuk, Wojciech P. Kozubski, Ewa Wysocka · 2017 · Oxidative Medicine and Cellular Longevity
57. α-Synuclein from platelets is not phosphorylated at serine 129 in Parkinson's disease and multiple system atrophy
    Clifford W. Shults, Jennifer M. Barrett, Deborah Fontaine · 2006 · Neuroscience Letters
58. Activities of respiratory chain complexes in isolated platelets in females with anorexia nervosa
    Marek Böhm, Hana Papežová, Hana Hansíková · 2007 · International Journal of Eating Disorders
59. Pathology of Neurodegenerative Diseases
    Young Soo Kim, Yun-Kyung Kim, Onyou Hwang, Jin Dong · 2012 · InTech eBooks
60. Platelet mitochondrial membrane potential in Parkinson's disease
    Paul M. A. Antony, Olga Boyd, Christophe Trefois et al. · 2014 · Annals of Clinical and Translational Neurology
61. Profiling genes related to mitochondrial function in mice treated with N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
    Guangyu Gu, Ariel Y. Deutch, Jeff Franklin, Shawn Levy, Douglas C. Wallace, Jing Zhang · 2003 · Biochemical and Biophysical Research Communications
62. Platelet cytochrome c-oxidase activity in patients with acute schizophrenia in the course of their treatment with risperidone
    Gulnur Sh. Burbaeva, И. С. Бокша, Marina S. Turishcheva, Olga Konstantinovna Savushkina, Alan G. Beniashvili, G. Rupchev, Morozova Ma · 2011 · Health
63. Platelets in Neurological Disorders
    Ilaria Canobbio, Gianni Francesco Guidetti, Mauro Torti · 2017 · Springer eBooks
64. Activation of Mitochondrial Complex II-Dependent Respiration Is Beneficial for α-Synucleinopathies
    Christina Fröhlich, Katja Zschiebsch, Victoria Gröger, Kristin Paarmann, Johannes Steffen, Christoph Thurm, Eva-Maria Schropp, Thomas Brüning, Frank Norbert Gellerich, Martin Radloff et al. · 2015 · Molecular Neurobiology
65. Unaltered cytochrome oxidase, glutamate dehydrogenase and glutaminase activities in platelets from patients with Sporadic Amyotrophic Lateral Sclerosis
    M. R. Gluck, R. G. Thomas, Mark A. Sivak · 2000 · Journal of Neural Transmission
66. Mitochondrial complex I deficiency occurs in skeletal muscle of a subgroup of individuals with Parkinson’s disease
    Simon Ulvenes Kverneng, Kjersti Eline Stige, Haakon Berven, Sepideh Mostafavi, Katarina Lundervold, Michele Brischigliaro, Brage Brakedal, Geir Olve Skeie, Irene Hana Flønes, Lilah Toker et al. · 2025 · Communications Medicine
67. Mitochondrial disorders in degenerative ataxias
    Ludger J. Schöls, Heinz Reichmann, George Amoiridis, Peter Seibel, S. Wagener, S. Seufert, H. Przuntek · 1996 · European Journal of Neurology
68. Mitochondria and Parkinson's Disease
    David K. Simon, Charleen T. Chu, Russell Howard Swerdlow · 2011 · Parkinson s Disease
69. Extracellular metabolisation of NADH by blood cells correlates with intracellular ATP levels
    Karl Nadlinger, Wilhelm Westerthaler, Danijela Storga-Tomic · 2002 · Biochimica et Biophysica Acta (BBA) - General Subjects
70. Parkinson's disease relevant pathological features are manifested in male Pink1/Parkin deficient rats
    Benjamin G. Lamberty, L. Daniel Estrella, Jane E. Mattingly, Katy M. Emanuel, Andrew J. Trease, Steven Totusek, Lexi Sheldon, Joseph W. George, Mohannad A. Almikhlafi, Trey Farmer et al. · 2023 · Brain Behavior & Immunity - Health
71. Parkinson's Disease
    Mario Rango · 2015 · International review of neurobiology
72. Mitochondrial Medicine
    Douglas C. Wallace, Marie T. Lott, Vincent Procaccio · 2013 · Elsevier eBooks
73. What's wrong with mitochondria in Parkinson's disease?
    J. Timothy Greenamyre · 2018 · Movement Disorders
74. Multiple system atrophy
    Wolfgang H. Oertel, Oliver Bandmann · 1999 · Journal of neural transmission. Supplementum
75. Nitric oxide-mediated mitochondrial impairment in neural cells: a role for glucose metabolism in neuroprotection
    Juan Pedro Bolaños, Paula Garcı́a-Nogales, Victoria Vega‐Agapito, María Delgado‐Esteban, Pilar Cidad, Ángeles Almeida · 2001 · Progress in brain research
76. More than microglia: myeloid cells and biomarkers in neurodegeneration
    Eleftheria Kodosaki, Rosie Bell, Aitana Sogorb‐Esteve, Katharine Wiltshire, Henrik Zetterberg, Amanda Heslegrave · 2024 · Frontiers in Neuroscience
77. Effectiveness of Albumin-Fused Thioredoxin against 6-Hydroxydopamine-Induced Neurotoxicity In Vitro
    Okina Sakakibara, Mikako Shimoda, Gaku Yamamoto, Youichirou Higashi, Mayumi Ikeda-Imafuku, Yu Ishima, Masahiro Kawahara, Ken‐ichiro Tanaka · 2023 · International Journal of Molecular Sciences
78. Mitochondrial Biology and Medicine
    Douglas C. Wallace, Marie T. Lott, Vincent Procaccio · 2019 · Elsevier eBooks
79. The Energy Crisis in Parkinson’s Disease: A Therapeutic Target
    Mhamad Abou-Hamdan, Emilie Cornille, Michel Khrestchatisky, M B A Barros de, Bouchra Gharib · 2011 · InTech eBooks
80. Mitochondrial respiratory chain enzyme activities, mtDNA variants and gene expression levels in idiopathic parkinson’s disease
    Ayşe Ercan, Gulnihal Kulaksiz-Erkmen, Özlem Dalmızrak, Meltem Müftüoğlu, İ. Hamdi Öğüş, Leyla Y. Cavdar, Levent Ertuğrul İnan, Nesrin Kartal Özer · 2009 · Turkish Journal of Biochemistry
81. The Use of Biomarkers for Prediction and Prevention of Alzheimer’s and Parkinson’s Diseases
    Silvia A. Mandel, Amos D. Korczyn · 2012 · Advances in predictive, preventive and personalised medicine
82. Characterization of basal ganglia dysfunction in Leber ?plus? disease
    Clemens Oliver Hanemann, Harald Hefter, Gottfried Schlaug, Rüdiger J. Seitz, Hans‐Joachim Freund, R. Benecke · 1996 · Journal of Neurology
83. Mitochondrial Function and Neurodegenerative Diseases
    Wilkins, Heather M., Weidling, Ian, Koppel, Scott, Wang, Xiaowan, von Schulze, Alex, Swerdlow, Russell H. · 2018 · The Molecular and Cellular Basis of Neurodegenerative Diseases
84. Glucosylsphingosine affects mitochondrial function in a neuronal cell model
    Valeria Nikolaenko, Reddy Vootukuri, Simon D. Eaton, Jenny Hällqvist, Tomas Baldwin, Kevin A. Mills, Wendy Heywood · 2025 · Communications Biology
85. Pink1/Parkin deficiency alters circulating lymphocyte populations and increases platelet-T cell aggregates in rats
    Jane E. Manganaro, Katy M. Emanuel, Benjamin G. Lamberty, Joseph W. George, Kelly L. Stauch · 2024 · Scientific Reports
86. Supramolecular Organization of the Respiratory Chain
    Janet Vonck · 2012 · Springer eBooks
87. Mitochondrial dysfunction in diabetes mellitus
    Christen M. Anderson · 1999 · Drug Development Research
88. Profiling peripheral immune cells in Parkinson’s disease: A Scoping Review
    Sherilyn Junelle Recinto, Janna E. Jernigan, Nadejda Lefter et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
89. Platelet mitochondrial complex I and IV activities are not reliable stratification biomarkers in Parkinson's disease
    Simon Ulvenes Kverneng, Sepideh Mostafavi, Yana Mikhaleva, Gard Aasmund Skulstad Johanson, Haakon Berven, Katarina Lundervold, Geir Olve Skeie, Erika Veslemøy Sheard, Mona Søgnen, Solveig Amdahl Af Geijerstam et al. · 2025 · Journal of Parkinson s Disease
90. Mitochondrial Dysfunction and Neurodegenerative Diseases
    Michael Lin, M. Flint Beal · 1998 · Springer eBooks
91. Multifactorial, biomarker-based model for assessing the state of patients with schizophrenia
    Е. Г. Черемных, Olga Konstantinovna Savushkina, T. A. Prokhorova, Svetlana A. Zozulya, I. N. Otman, A. N. Pozdnyakova, Natalia S. Karpova, Yuri Shilov, Tatiana P. Klyushnik · 2024 · Bulletin of Siberian Medicine
92. Mitochondria and Parkinson’s Disease
    Russell Howard Swerdlow · 2001 · Humana Press eBooks
93. Prediction and targeted prevention of Parkinson's and Alzheimer's diseases
    Silvia A. Mandel, Ilan J. Y. Halperin, Amos D. Korczyn, Micaela Morelli · 2009
94. Biomarkers of Alzheimer's and Parkinson's Disease
    Walter Maetzler, Daniela Berg · 2010 · Biomarkers
95. Aging and Degenerative Diseases
    Douglas C. Wallace · 1999 · Springer eBooks
96. Morbus Parkinson — Gehirnerkrankung oder Ganzkörpererkrankung?
    Heinz Reichmann, Tjalf Ziemssen · 2003 · Steinkopff eBooks
97. REDOX PROTEOMICS IDENTIFICATION OF OXIDATIVELY MODIFIED PROTEINS AND THEIR PHARMACOLOGICAL MODULATION: INSIGHT INTO OXIDATIVE STRESS IN BRAIN AGING, AGE-RELATED COGNITIVE IMPAIRMENT
    H. Fai Poon · 2005 · UKnowledge (University of Kentucky)
98. The impact of developmental stress on the functioning and vulnerability of CNS neurons
    Ilse Sanet Pienaar · 2008 · SUNScholar (Stellenbosch University)
99. Molecular Pathways of Mitochondrial Dysfunction in Neurodegeneration: the Paradigms of Parkinson's and Huntington's Diseases
    Ana Cristina Rego, Sandra M. Cardoso, Catarina Resende Oliveira · 2007 · Springer eBooks
100. Platelets as Peripheral Model of Glutamate-Related Excitotoxicity in Parkinson’s Disease
     Carlo Ferrarese, Graziella Bianchi, Marianna Bugiani et al. · 1996 · Neurodegenerative Diseases